Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Year: 2024
Type: editorial
Authors: Arjun Pennathur, Michael Lanuti, Robert E. Merritt, Andrea Wolf, Homa Keshavarz, Billy W. Loo, Robert D. Suh, Raymond H. Mak, Alessandro Brunelli, Gerard J. Criner, Peter J. Mazzone, Garrett Walsh, Michael Liptay, Q. Eileen Wafford, Sudish Murthy, M. Blair Marshall, Betty Tong, Brian Pettiford, Gaetano Rocco, James Luketich, Matthew J. Schuchert, Thomas K. Varghese, Thomas A. D’Amico, Scott J. Swanson
Institutions: University of Pittsburgh, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Massachusetts General Hospital, The Ohio State University Wexner Medical Center, Mount Sinai Health System, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, American Association for Thoracic Surgery, McMaster University, Stanford Medicine, Stanford Cancer Institute, Stanford University, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, St James's University Hospital, Temple University, Cleveland Clinic, The University of Texas MD Anderson Cancer Center, Rush University Medical Center, Sarasota Memorial Hospital, Duke University Hospital, Ochsner Health System, Ochsner Medical Center, Memorial Sloan Kettering Cancer Center, University of Utah, Huntsman Cancer Institute, Duke University, Duke Cancer Institute, Harvard University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405286898